Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Kondili LA, Gaeta GB, Ieluzzi D, Zignego AL, Monti M, Gori A, Soria A, Raimondo G, Filomia R, Di Leo A, Iannone A, Massari M, Corsini R, Gulminetti R, Gatti Comini A, Toniutto P, Dissegna D, Russo FP, Zanetto A, Rumi MG, Brancaccio G, Danieli E, Brunetto MR, Weimer LE, Quaranta MG, Vella S, Puoti M.

PLoS One. 2018 Jan 2;13(1):e0190803. doi: 10.1371/journal.pone.0190803. eCollection 2018.

2.

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.

Kondili LA, Gaeta GB, Brunetto MR, Di Leo A, Iannone A, Santantonio TA, Giammario A, Raimondo G, Filomia R, Coppola C, Amoruso DC, Blanc P, Del Pin B, Chemello L, Cavalletto L, Morisco F, Donnarumma L, Rumi MG, Gasbarrini A, Siciliano M, Massari M, Corsini R, Coco B, Madonia S, Cannizzaro M, Zignego AL, Monti M, Russo FP, Zanetto A, Persico M, Masarone M, Villa E, Bernabucci V, Taliani G, Biliotti E, Chessa L, Pasetto MC, Andreone P, Margotti M, Brancaccio G, Ieluzzi D, Borgia G, Zappulo E, Calvaruso V, Petta S, Falzano L, Quaranta MG, Weimer LE, Rosato S, Vella S, Giannini EG.

PLoS One. 2017 Oct 4;12(10):e0185728. doi: 10.1371/journal.pone.0185728. eCollection 2017.

3.

Update on Chemotherapy-Induced Peripheral Neuropathy.

Cioroiu C, Weimer LH.

Curr Neurol Neurosci Rep. 2017 Jun;17(6):47. doi: 10.1007/s11910-017-0757-7. Review.

PMID:
28421360
4.

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Kondili LA, Gaeta GB, Ieluzzi D, Zignego AL, Monti M, Gori A, Soria A, Raimondo G, Filomia R, Di Leo A, Iannone A, Massari M, Corsini R, Gulminetti R, Gatti Comini A, Toniutto P, Dissegna D, Russo FP, Zanetto A, Rumi MG, Brancaccio G, Danieli E, Brunetto MR, Weimer LE, Quaranta MG, Vella S, Puoti M.

PLoS One. 2017 Feb 28;12(2):e0172159. doi: 10.1371/journal.pone.0172159. eCollection 2017. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190803.

5.

Syncope: Case Studies.

Kleyman I, Weimer LH.

Neurol Clin. 2016 Aug;34(3):525-45. doi: 10.1016/j.ncl.2016.04.002. Review.

PMID:
27445240
6.

HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.

Michelini Z, Galluzzo CM, Pirillo MF, Francisci D, Degli Antoni A, Vivarelli A, Ladisa N, Cirioni O, Weimer LE, Fragola V, Cara A, Floridia M, Baroncelli S.

J Med Virol. 2016 Dec;88(12):2115-2124. doi: 10.1002/jmv.24581. Epub 2016 May 30.

PMID:
27197719
7.

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy.

Degli Antoni A, Weimer LE, Fragola V, Giacometti A, Sozio F.

West Indian Med J. 2015 Jun;64(3):291-3. doi: 10.7727/wimj.2014.066. Epub 2015 Jul 14.

8.

Bortezomib-associated demyelinating neuropathy--clinical and pathologic features.

Thawani SP, Tanji K, De Sousa EA, Weimer LH, Brannagan TH 3rd.

J Clin Neuromuscul Dis. 2015 Jun;16(4):202-9. doi: 10.1097/CND.0000000000000077.

PMID:
25996966
9.

Long-term Maraviroc Therapy and Limited Side Effects in an HIV-1 Experienced Patient: Six Years of Antiretroviral Observation.

Cirioni O, Weimer LE, Fragola V, Giacometti A, Sozio F.

West Indian Med J. 2014 Dec;63(7):785-7. doi: 10.7727/wimj.2014.068. Epub 2014 Aug 29. No abstract available.

10.

A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation.

Cirioni O, Weimer LE, Fragola V, Giacometti A, Ancarani F, Maracci M, Gabrielli E, Marchionni E, Pirillo MF, Vella S.

West Indian Med J. 2014 Dec;63(7):779-84. doi: 10.7727/wimj.2013.264. Epub 2013 Sep 3.

11.

Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients.

Bucciardini R, Pugliese K, Weimer L, Digregorio M, Fragola V, Mancini M, Maroccia Z, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Guaraldi G, Cirioni O, Ortu F, Parruti G, Mannazzu M, Libertone R, Donnini S, Floridia M; ISS-NIA Study Group.

HIV Clin Trials. 2014 Jul-Aug;15(4):176-83. doi: 10.1310/hct1504-176.

PMID:
25143026
12.

Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.

Ruzhansky K, Scoon J, Weimer LH, Maurer MS, Berk JL, Brannagan TH 3rd.

J Clin Neuromuscul Dis. 2014 Sep;16(1):1-6. doi: 10.1097/CND.0000000000000040.

PMID:
25137508
13.

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

Baroncelli S, Pirillo MF, Galluzzo CM, Antoni AD, Ladisa N, Francisci D, d'Ettorre G, Segala D, Vivarelli A, Sozio F, Cirioni O, Weimer LE, Fragola V, Parruti G, Floridia M.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):71-7. doi: 10.1089/AID.2014.0060.

14.

Neurologic complications of alcoholism.

Noble JM, Weimer LH.

Continuum (Minneap Minn). 2014 Jun;20(3 Neurology of Systemic Disease):624-41. doi: 10.1212/01.CON.0000450970.99322.84. Review.

PMID:
24893238
15.

Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.

Francisci D, Falcinelli E, Baroncelli S, Petito E, Cecchini E, Weimer LE, Floridia M, Gresele P, Baldelli F.

Scand J Infect Dis. 2014 Jun;46(6):466-70. doi: 10.3109/00365548.2014.898332. Epub 2014 Apr 16.

PMID:
24738757
16.

HIV-1 coreceptor switch during 2 years of structured treatment interruptions.

Baroncelli S, Galluzzo CM, Andreotti M, Pirillo MF, Fragola V, Weimer LE, Giuliano M, Vella S, Palmisano L.

Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1565-70. doi: 10.1007/s10096-013-1911-z. Epub 2013 Jul 4.

PMID:
24213914
17.

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.

Baroncelli S, Villani P, Galluzzo CM, Cavalli A, Volpe A, Francisci D, Vivarelli A, Sozio F, Tedeschi S, Cirioni O, Sighinolfi L, Cusato M, Pirillo MF, Weimer LE, Fragola V, Parruti G, Regazzi M, Floridia M.

Ther Drug Monit. 2013 Dec;35(6):785-90. doi: 10.1097/FTD.0b013e31829ad690.

PMID:
24061444
19.
20.

Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD).

D'Amico E, Pasmantier M, Lee YW, Weimer L, Mitsumoto H.

Muscle Nerve. 2013 Jan;47(1):28-32. doi: 10.1002/mus.23496. Epub 2012 Nov 21. Erratum in: Muscle Nerve. 2014 Oct;50(4):619.

21.

No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.

Baroncelli S, Mezzaroma I, Fantauzzi A, Galluzzo CM, Antoni AD, Vullo V, Francisci D, Ladisa N, Vivarelli A, Cirioni O, Sighinolfi L, Weimer LE, Fragola V, Fidanza R, Cara A, Palmisano L.

Antivir Ther. 2013;18(3):321-7. doi: 10.3851/IMP2433. Epub 2012 Oct 9.

PMID:
23047152
22.

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.

Weimer LE, Fragola V, Floridia M, Guaraldi G, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Parruti G, Giacometti A, Manconi PE, Vivarelli A, D'Ettorre G, Mura MS, Cicalini S, Preziosi R, Sighinolfi L, Verucchi G, Libertone R, Tavio M, Sarmati L, Bucciardini R; ISS-NIA Study Group.

J Antimicrob Chemother. 2013 Jan;68(1):193-9. doi: 10.1093/jac/dks341. Epub 2012 Sep 14.

23.

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

Bucciardini R, D'Ettorre G, Baroncelli S, Ceccarelli G, Parruti G, Weimer LE, Fragola V, Galluzzo CM, Pirillo MF, Lucattini S, Bellagamba R, Francisci D, Ladisa N, Degli Antoni A, Guaraldi G, Manconi PE, Vullo V, Preziosi R, Cirioni O, Verucchi G, Floridia M; ISS-NIA study group.

Int J STD AIDS. 2012 Jul;23(7):459-63.

PMID:
22843997
24.

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

Baroncelli S, Galluzzo CM, Weimer LE, Pirillo MF, Volpe A, Mercuri A, Cavalli A, Fragola V, Monno L, Degli Antoni A, Ladisa N, Francisci D, Bucciardini R, Floridia M.

J Antimicrob Chemother. 2012 Jun;67(6):1479-85. doi: 10.1093/jac/dks055. Epub 2012 Feb 23.

25.

Hemifacial spasm associated with intraparenchymal brain stem tumor.

Leonardos A, Greene PE, Weimer LH, Khandji AG, Mazzoni P.

Mov Disord. 2011 Nov;26(13):2325-6. doi: 10.1002/mds.23877. No abstract available.

PMID:
22109850
26.

Maternal HIV status and infant feeding practices among Ugandan women.

Okong P, Namaganda PK, Bassani L, Tabaro MM, Zanetto F, Mwebaze EB, Weimer L, Tomasoni L, Castelli F, Giuliano M.

SAHARA J. 2010 Jul;7(1):24-9.

PMID:
21409292
27.

HIV-2 infection, end-stage renal disease and protease inhibitor intolerance: which salvage regimen?

Francisci D, Martinelli L, Weimer LE, Zazzi M, Floridia M, Masini G, Baldelli F.

Clin Drug Investig. 2011;31(5):345-9. doi: 10.2165/11539940-000000000-00000.

PMID:
21344955
28.

Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy.

Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD.

Breast Cancer Res Treat. 2011 Feb;125(3):767-74. doi: 10.1007/s10549-010-1278-0. Epub 2010 Dec 3.

PMID:
21128110
29.

Experience with the Awaji Island modifications to the ALS diagnostic criteria.

Chen A, Weimer L, Brannagan T 3rd, Colin M, Andrews J, Mitsumoto H, Kaufmann P.

Muscle Nerve. 2010 Nov;42(5):831-2. doi: 10.1002/mus.21841.

PMID:
20928911
30.

Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation.

Parsons T, Weimer L, Engelstad K, Linker A, Battista V, Wei Y, Hirano M, Dimauro S, De Vivo DC, Kaufmann P.

Arch Neurol. 2010 Aug;67(8):976-9. doi: 10.1001/archneurol.2010.174.

PMID:
20697048
31.

Development of recurrent facial palsy during plasmapheresis in Guillain-Barré syndrome: a case report.

Stevenson ML, Weimer LH, Bogorad IV.

J Med Case Rep. 2010 Aug 6;4:253. doi: 10.1186/1752-1947-4-253.

32.

Autonomic testing: common techniques and clinical applications.

Weimer LH.

Neurologist. 2010 Jul;16(4):215-22. doi: 10.1097/NRL.0b013e3181cf86ab. Review.

PMID:
20592565
33.

Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.

Pirillo M, Palmisano L, Pellegrini M, Galluzzo C, Weimer L, Bucciardini R, Fragola V, Andreotti M, Marchei E, Pichini S, Vella S, Giuliano M.

AIDS Res Hum Retroviruses. 2010 May;26(5):541-5. doi: 10.1089/aid.2009.0116.

PMID:
20455761
35.

Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.

Baroncelli S, Villani P, Weimer LE, Ladisa N, Francisci D, Tommasi C, Vullo V, Preziosi R, Cicalini S, Cusato M, Galluzzo C, Floridia M, Regazzi M; ISS-NIA Group.

Ann Pharmacother. 2010 May;44(5):838-43. doi: 10.1345/aph.1M688. Epub 2010 Apr 6.

PMID:
20371753
36.

Absence of heart failure in severe cardiac and autonomic amyloidosis: the essential role of sympathetic activation and venous tone in the development of the congestive heart failure syndrome.

Abramov D, Weimer LH, Marboe CC, Shimbo D, King DL, Maurer MS.

Congest Heart Fail. 2009 Nov-Dec;15(6):288-90. doi: 10.1111/j.1751-7133.2009.00058.x. No abstract available.

37.

Immediate versus delayed surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy: a randomized open-label study.

Narciso P, Bucciardini R, Tozzi V, Bellagamba R, Ivanovic J, Giulianelli M, Scevola S, Palummieri A, Fragola V, Massella M, Fracasso L, De Vita R, Pierro P, Del Maestro A, Mirra M, Weimer L.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):979-87. doi: 10.1089/aid.2009.0029.

PMID:
19795984
38.

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

Baroncelli S, Galluzzo CM, Pirillo MF, Mancini MG, Weimer LE, Andreotti M, Amici R, Vella S, Giuliano M, Palmisano L.

J Clin Virol. 2009 Dec;46(4):367-70. doi: 10.1016/j.jcv.2009.09.011. Epub 2009 Sep 25.

PMID:
19782638
39.

The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.

Palmisano L, Giuliano M, Galluzzo CM, Amici R, Andreotti M, Weimer LE, Pirillo MF, Fragola V, Bucciardini R, Vella S.

HIV Med. 2009 Sep;10(8):477-81. doi: 10.1111/j.1468-1293.2009.00715.x. Epub 2009 May 6.

40.

Neurological aspects of syncope and orthostatic intolerance.

Weimer LH, Zadeh P.

Med Clin North Am. 2009 Mar;93(2):427-49, ix. doi: 10.1016/j.mcna.2008.10.002. Review.

PMID:
19272517
41.

Update on medication-induced peripheral neuropathy.

Weimer LH, Sachdev N.

Curr Neurol Neurosci Rep. 2009 Jan;9(1):69-75. Review.

PMID:
19080756
42.

Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.

Palmisano L, Giuliano M, Bucciardini R, Andreotti M, Fragola V, Pirillo MF, Weimer LE, Mancini MG, Vella S.

J Med Microbiol. 2009 Jan;58(Pt 1):121-4. doi: 10.1099/jmm.0.004630-0.

PMID:
19074663
43.

Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.

Palmisano L, Giuliano M, Bucciardini R, Fragola V, Andreotti M, Galluzzo C, Pirillo MF, Weimer LE, Arcieri R, Germinario EA, Amici R, Mancini MG, Monforte Ad, Castelli F, Caramello P, Vella S; Italian ISS-PART Clinical Centers.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):39-47.

PMID:
17972364
44.

The electrodiagnosis of neuropathy: basic principles and common pitfalls.

Gooch CL, Weimer LH.

Neurol Clin. 2007 Feb;25(1):1-28. Review.

PMID:
17324718
45.

Multifocal motor neuropathy with conduction block: slow but not benign.

Lange DJ, Weimer LH, Trojaborg W, Lovelace RE, Gooch CL, Rowland LP.

Arch Neurol. 2006 Dec;63(12):1778-81.

PMID:
17172619
46.

Randomized controlled phase II trial of glatiramer acetate in ALS.

Gordon PH, Doorish C, Montes J, Mosley RL, Diamond B, Macarthur RB, Weimer LH, Kaufmann P, Hays AP, Rowland LP, Gendelman HE, Przedborski S, Mitsumoto H.

Neurology. 2006 Apr 11;66(7):1117-9. Erratum in: Neurology. 2006 Sep 12;67(5):920. Mosely, R L [corrected to Mosley, RL].

PMID:
16606934
47.

Immune-mediated autonomic neuropathies.

Etienne M, Weimer LH.

Curr Neurol Neurosci Rep. 2006 Jan;6(1):57-64. Review.

PMID:
16469272
48.

Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.

Weimer LH, Podwall D.

J Neurol Sci. 2006 Mar 15;242(1-2):47-54. Epub 2005 Dec 28.

PMID:
16386273
49.

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL.

J Clin Invest. 2005 Dec;115(12):3579-86.

50.

Medication and toxin-induced peripheral neuropathy.

Pratt RW, Weimer LH.

Semin Neurol. 2005 Jun;25(2):204-16. Review.

PMID:
15937736

Supplemental Content

Loading ...
Support Center